HMGB-1 as a predictor of major bleeding requiring activation of a massive transfusion protocol in severe trauma
Abstract Massive bleeding causes approximately 50% of deaths in patients with major trauma. Most patients die within 6 h of injury, which is preventable in at least 10% of cases. For these patients, early activation of the massive transfusion protocol (MTP) is a critical survival factor. With severe...
Saved in:
Main Authors: | Michal Frelich, Marek Bebej, Jan Pavlíček, Filip Burša, Vojtěch Vodička, Zdeněk Švagera, Adéla Kondé, Ondřej Jor, Markéta Bílená, Tereza Romanová, Peter Sklienka |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-89139-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tailoring transfusion strategy using thromboelastogram in goal-directed massive transfusion: Impact on transfusion requirements and clinical outcomes
by: P. A. Prethika, et al.
Published: (2024-01-01) -
Platelet-derived HMGB1 induces NETosis, exacerbating brain damage in the photothrombotic stroke model
by: Sang-A. Oh, et al.
Published: (2025-02-01) -
ROS anchor PAMPs-mediated extracellular HMGB1 self-association and its dimerization enhances pro-inflammatory signaling
by: Man Sup Kwak, et al.
Published: (2025-03-01) -
Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers
by: Xin Wang, et al.
Published: (2025-02-01) -
An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A, as a novel therapeutic approach to inflammatory diseases
by: Kari Ann Shirey, et al.
Published: (2025-02-01)